Signal active
Investment Firm
Overview
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.
Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.
Highlights
1985
Venture Capital
11-50
306
63
93
Early Stage Venture, Late Stage Venture, Seed
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Domain Associates, established in 1985 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Information Technology, Biotechnology, Computer, Consumer, Health Care, Pharmaceutical, Medical Device, Life Science, Financial Services, Finance. The organization boasts a portfolio of 306 investments, with an average round size of $28.7M and 93 successful exits. Their recent investments include Neuron Systems, Johnson & Johnson Development Corporation, ProteinSimple, Mitsui Global Investment, Wellcome Trust. The highest investment round they participated in was $601.4B. Among their most notable exits are Neuron Systems and Johnson & Johnson Development Corporation. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
306
39
63
93
Investments
306
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Oct 13, 2021 | Axial Biotherapeutics | Biotechnology | 37.3M |
Nov 03, 2021 | Antios Therapeutics | Biotechnology | 75.0M |
Aug 15, 2022 | Fractyl Health | Biotechnology | null |
Apr 14, 2023 | - | - | 24.0M |
Exits
93
Funding Timeline
306
0
4
Funding Rounds
306
Domain Associates has raised 306 rounds. Their latest funding was raised on Apr 14, 2023 from a Series G - Epic Sciences round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Oct 13, 2021 | Series C - Axial Biotherapeutics | - | 37.3M | - |
Nov 03, 2021 | Series B - Antios Therapeutics | - | 75.0M | - |
Aug 15, 2022 | Series F - Fractyl Health | - | 0 | - |
Apr 14, 2023 | Series G - Epic Sciences | - | 24.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.